Centogene (CNTGF, $0.15) was a top weekly loser, falling to $0.15 per share. Of the 405 stocks analyzed in the Medical Specialties Industry throughout the week of April 4/14/2025 - 4/21/2025, 2025, of them (5) exhibited an Uptrend while of them (4) were in a Downtrend. 404 similar cases when CNTGF's price dropped within one week were found. In of those 404 cases, CNTGF's price went down during the subsequent month. Based on these historical data, the odds of a Downtrend continuation for CNTGF are
a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies